RVTY:NYSE
Revvity Inc
US$82.26
arrow_downward
-3.43%(-2.92) 1D
US$82.00
arrow_downward
-0.32% (-0.26)bedtimeවේලාවෙන් පසු
වසා ඇත: බක් 29, 16.00.03 ග්රිමවේ-4 · USD
search
සියලු සංකේත
1D
5D
1M
6M
YTD
1Y
5Y
උපරි
| සංකේතය | මිල | වෙනස් කිරීම | % වෙනස |
|---|
insights_autoRVTY සඳහා ඉහළම ඇතුළාන්තයන් උත්පාදනය කරමින්...
විවෘත කරන්න
US$84.31
ඉහළ
US$85.52
පහළ
US$81.22
වෙ.පො ප්රාග්ධනය
බි9.52
දළ පරිමාව
ද962.77
හඬ පරිමාණය
මි1.21
සති-52 ඉහළ
US$118.30
සති-52 පහළ
US$81.22
බීටා
1.13
ගෙවිය යුතු කොටස්
මි111.80
සේවකයින් ගණන
ද11
පුවත් සහ කථා
වෙබය හරහා මූලාශ්ර වෙතින්
GuruFocus
·
පැය 2කට පෙර
Is Revvity Inc (RVTY) a Bargain After 3.4% Drop? GF Value Says U
Investing.com
·
පැය 6කට පෙර
Revvity stock hits 52-week low at 81.28 USD
පැතිකඩ
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. Wikipedia
Revvity Inc ගැන
CEOPrahlad Singh
සේවකයින්ද11
ආරම්භ කළේ1947
මූලස්ථානයWaltham, මසාචුසෙට්ස්, එක්සත් ජනපදය
අංශය-
වෙබ් අඩවියrevvity.com
AI අන්තර්ගතයේ වැරදි ඇතුළත් විය හැක. තව දැන ගන්න